Abstract | BACKGROUND: METHODS: RESULTS: In the FGF(+) group, the mean linear intercept value of the alveolar septa was significantly shorter on the treated side than on the untreated side (65.1 ± 7.0 vs 114.4 ± 7.5 μm; P = .0005). There was no significant difference in the mean linear intercept value between the treated and untreated sides in the FGF(-) group. CONCLUSIONS:
|
Authors | Mitsumasa Kawago, Tatsuya Yoshimasu, Yasuhiko Tabata, Masaya Yamamoto, Yoshimitsu Hirai, Takahiro Kinoshita, Yoshitaka Okamura |
Journal | The Journal of thoracic and cardiovascular surgery
(J Thorac Cardiovasc Surg)
Vol. 147
Issue 5
Pg. 1644-9
(May 2014)
ISSN: 1097-685X [Electronic] United States |
PMID | 24021953
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Crown Copyright © 2014. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Drug Carriers
- Drug Implants
- Recombinant Proteins
- Fibroblast Growth Factor 2
- Gelatin
- Pancreatic Elastase
|
Topics |
- Animals
- Disease Models, Animal
- Drug Administration Routes
- Drug Carriers
- Drug Implants
- Female
- Fibroblast Growth Factor 2
(administration & dosage)
- Gelatin
- Humans
- Lung
(drug effects, pathology, physiopathology)
- Pancreatic Elastase
- Pleural Cavity
- Pulmonary Emphysema
(chemically induced, drug therapy, pathology, physiopathology)
- Rats
- Rats, Sprague-Dawley
- Recombinant Proteins
(administration & dosage)
- Regeneration
(drug effects)
|